306 related articles for article (PubMed ID: 28869592)
1. Reconstruction of enhancer-target networks in 935 samples of human primary cells, tissues and cell lines.
Cao Q; Anyansi C; Hu X; Xu L; Xiong L; Tang W; Mok MTS; Cheng C; Fan X; Gerstein M; Cheng ASL; Yip KY
Nat Genet; 2017 Oct; 49(10):1428-1436. PubMed ID: 28869592
[TBL] [Abstract][Full Text] [Related]
2. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
3. Inferring regulatory element landscapes and transcription factor networks from cancer methylomes.
Yao L; Shen H; Laird PW; Farnham PJ; Berman BP
Genome Biol; 2015 May; 16(1):105. PubMed ID: 25994056
[TBL] [Abstract][Full Text] [Related]
4. A semi-supervised approach uncovers thousands of intragenic enhancers differentially activated in human cells.
González-Vallinas J; Pagès A; Singh B; Eyras E
BMC Genomics; 2015 Jul; 16(1):523. PubMed ID: 26169177
[TBL] [Abstract][Full Text] [Related]
5. [Methylation of mismatch repair gene (MMR) in primary hepatocellular carcinoma].
Zhang CJ; Li HM; Yau LM; Suen KW; Zhou GY; Yu F; Liew CT
Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):433-6. PubMed ID: 15498213
[TBL] [Abstract][Full Text] [Related]
6. Methylation status of genes upregulated by demethylating agent 5-aza-2'-deoxycytidine in hepatocellular carcinoma.
Hirasawa Y; Arai M; Imazeki F; Tada M; Mikata R; Fukai K; Miyazaki M; Ochiai T; Saisho H; Yokosuka O
Oncology; 2006; 71(1-2):77-85. PubMed ID: 17341888
[TBL] [Abstract][Full Text] [Related]
7. Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2.
Stefanska B; Suderman M; Machnes Z; Bhattacharyya B; Hallett M; Szyf M
Carcinogenesis; 2013 Dec; 34(12):2738-49. PubMed ID: 23955541
[TBL] [Abstract][Full Text] [Related]
8. Global Analysis of Enhancer Targets Reveals Convergent Enhancer-Driven Regulatory Modules.
Xie S; Armendariz D; Zhou P; Duan J; Hon GC
Cell Rep; 2019 Nov; 29(9):2570-2578.e5. PubMed ID: 31775028
[TBL] [Abstract][Full Text] [Related]
9. ANANSE: an enhancer network-based computational approach for predicting key transcription factors in cell fate determination.
Xu Q; Georgiou G; Frölich S; van der Sande M; Veenstra GJC; Zhou H; van Heeringen SJ
Nucleic Acids Res; 2021 Aug; 49(14):7966-7985. PubMed ID: 34244796
[TBL] [Abstract][Full Text] [Related]
10. Active medulloblastoma enhancers reveal subgroup-specific cellular origins.
Lin CY; Erkek S; Tong Y; Yin L; Federation AJ; Zapatka M; Haldipur P; Kawauchi D; Risch T; Warnatz HJ; Worst BC; Ju B; Orr BA; Zeid R; Polaski DR; Segura-Wang M; Waszak SM; Jones DT; Kool M; Hovestadt V; Buchhalter I; Sieber L; Johann P; Chavez L; Gröschel S; Ryzhova M; Korshunov A; Chen W; Chizhikov VV; Millen KJ; Amstislavskiy V; Lehrach H; Yaspo ML; Eils R; Lichter P; Korbel JO; Pfister SM; Bradner JE; Northcott PA
Nature; 2016 Feb; 530(7588):57-62. PubMed ID: 26814967
[TBL] [Abstract][Full Text] [Related]
11. Computational identification of active enhancers in model organisms.
Wang C; Zhang MQ; Zhang Z
Genomics Proteomics Bioinformatics; 2013 Jun; 11(3):142-50. PubMed ID: 23685394
[TBL] [Abstract][Full Text] [Related]
12. Decreased Expression of BNC1 and BNC2 Is Associated with Genetic or Epigenetic Regulation in Hepatocellular Carcinoma.
Wu Y; Zhang X; Liu Y; Lu F; Chen X
Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26821013
[TBL] [Abstract][Full Text] [Related]
13. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
14. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.
Schagdarsurengin U; Wilkens L; Steinemann D; Flemming P; Kreipe HH; Pfeifer GP; Schlegelberger B; Dammann R
Oncogene; 2003 Mar; 22(12):1866-71. PubMed ID: 12660822
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
16. Integrated analyses to reconstruct microRNA-mediated regulatory networks in mouse liver using high-throughput profiling.
Hsu SD; Huang HY; Chou CH; Sun YM; Hsu MT; Tsou AP
BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S12. PubMed ID: 25707768
[TBL] [Abstract][Full Text] [Related]
17. The recently identified modifier of murine metastable epialleles, Rearranged L-Myc Fusion, is involved in maintaining epigenetic marks at CpG island shores and enhancers.
Harten SK; Oey H; Bourke LM; Bharti V; Isbel L; Daxinger L; Faou P; Robertson N; Matthews JM; Whitelaw E
BMC Biol; 2015 Mar; 13():21. PubMed ID: 25857663
[TBL] [Abstract][Full Text] [Related]
18. DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721.
Fan H; Zhao Z; Quan Y; Xu J; Zhang J; Xie W
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):952-61. PubMed ID: 18049164
[TBL] [Abstract][Full Text] [Related]
19. High throughput technologies for the functional discovery of mammalian enhancers: new approaches for understanding transcriptional regulatory network dynamics.
Dailey L
Genomics; 2015 Sep; 106(3):151-158. PubMed ID: 26072436
[TBL] [Abstract][Full Text] [Related]
20. The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma.
He XX; Kuang SZ; Liao JZ; Xu CR; Chang Y; Wu YL; Gong J; Tian DA; Guo AY; Lin JS
Mol Biosyst; 2015 Feb; 11(2):532-9. PubMed ID: 25424171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
